Conference Coverage

PEXIVAS trial results will likely change ANCA-associated vasculitis therapy

Publish date: October 25, 2018

 

REPORTING FROM THE ACR ANNUAL MEETING

SOURCE: Merkel PA et al. Arthritis Rheumatol. 2018;70(Suppl 10):Abstract 2788.

Pages

Recommended Reading

Decision aid aims to make lupus nephritis treatment decisions more understandable
MDedge Internal Medicine
Guideline-recommended tests’ prognostic ability affirmed in prostanoid-treated PAH
MDedge Internal Medicine
Pregnancy registries are a valuable resource
MDedge Internal Medicine
Two distinct subtypes of SLE-linked pulmonary arterial hypertension described
MDedge Internal Medicine
Anti-RNPC3 antibody positive status linked to GI dysmotility in systemic sclerosis
MDedge Internal Medicine
Antimalarial-induced cardiomyopathy in lupus may be underrecognized
MDedge Internal Medicine
PET/CT has good accuracy for diagnosing GCA
MDedge Internal Medicine
Case review: Posttransplant lupus nephritis recurrence rates declining
MDedge Internal Medicine
SLE low-disease definition receives prospective validation
MDedge Internal Medicine
Drafts of new classification criteria presented for GCA, Takayasu’s arteritis
MDedge Internal Medicine